NO960268L - Nye dialkoksypyridinylbenzimidazolderivater - Google Patents
Nye dialkoksypyridinylbenzimidazolderivaterInfo
- Publication number
- NO960268L NO960268L NO960268A NO960268A NO960268L NO 960268 L NO960268 L NO 960268L NO 960268 A NO960268 A NO 960268A NO 960268 A NO960268 A NO 960268A NO 960268 L NO960268 L NO 960268L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methyl
- new
- dialkoxypyridinylbenzimidazole
- derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 5
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- -1 3,4-dimethoxy-2-pyridinyl Chemical group 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000220304 Prunus dulcis Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- HSXYQKWENGEZMK-UHFFFAOYSA-N methyl 2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1-[(2-hydroxy-2-phenylacetyl)oxymethyl]-6-methylbenzimidazole-5-carboxylate Chemical compound C1=2C=C(C)C(C(=O)OC)=CC=2N=C(S(=O)CC=2C(=C(OC)C=CN=2)OC)N1COC(=O)C(O)C1=CC=CC=C1 HSXYQKWENGEZMK-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000012450 pharmaceutical intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25617194A | 1994-05-27 | 1994-05-27 | |
| SE9400511 | 1994-05-27 | ||
| PCT/SE1995/000519 WO1995032959A1 (en) | 1994-05-27 | 1995-05-11 | Novel dialkoxy-pyridinyl-benzimidazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO960268D0 NO960268D0 (no) | 1996-01-23 |
| NO960268L true NO960268L (no) | 1996-01-23 |
Family
ID=20392945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960268A NO960268L (no) | 1994-05-27 | 1996-01-23 | Nye dialkoksypyridinylbenzimidazolderivater |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0712401A1 (pt) |
| JP (1) | JPH09504557A (pt) |
| CN (1) | CN1128997A (pt) |
| AU (1) | AU2633095A (pt) |
| BR (1) | BR9506235A (pt) |
| CA (1) | CA2166988A1 (pt) |
| CZ (1) | CZ24396A3 (pt) |
| EE (1) | EE9600011A (pt) |
| FI (1) | FI960367A0 (pt) |
| HU (1) | HU9600005D0 (pt) |
| IL (1) | IL113604A0 (pt) |
| IS (1) | IS4321A (pt) |
| MA (1) | MA23563A1 (pt) |
| NO (1) | NO960268L (pt) |
| PL (1) | PL312692A1 (pt) |
| TN (1) | TNSN95062A1 (pt) |
| WO (1) | WO1995032959A1 (pt) |
| ZA (1) | ZA954125B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
| GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| JP4610086B2 (ja) | 1998-11-18 | 2011-01-12 | アストラゼネカ・アクチエボラーグ | 改善された化学的方法および医薬処方物 |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| WO2008057802A2 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
| CN101980700A (zh) | 2008-02-20 | 2011-02-23 | 密苏里大学董事会 | 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法 |
| CN102209529A (zh) | 2008-09-09 | 2011-10-05 | 阿斯利康(瑞典)有限公司 | 将药物组合物递送至有需要的患者的方法 |
| SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
| US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0593463B1 (en) * | 1990-06-20 | 1999-09-15 | Astra Aktiebolag | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/fr unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/xx unknown
- 1995-05-11 HU HU9600005A patent/HU9600005D0/hu unknown
- 1995-05-11 BR BR9506235A patent/BR9506235A/pt not_active Application Discontinuation
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/en not_active Application Discontinuation
- 1995-05-11 PL PL95312692A patent/PL312692A1/xx unknown
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-11 CN CN95190482A patent/CN1128997A/zh active Pending
- 1995-05-11 CA CA002166988A patent/CA2166988A1/en not_active Abandoned
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/cs unknown
- 1995-05-11 EE EE9600011A patent/EE9600011A/xx unknown
- 1995-05-11 EP EP95921187A patent/EP0712401A1/en not_active Withdrawn
- 1995-05-11 JP JP8500730A patent/JPH09504557A/ja active Pending
- 1995-05-19 ZA ZA954125A patent/ZA954125B/xx unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/fr unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/is unknown
- 1996-01-23 NO NO960268A patent/NO960268L/no unknown
- 1996-01-26 FI FI960367A patent/FI960367A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL113604A0 (en) | 1995-08-31 |
| CZ24396A3 (en) | 1996-06-12 |
| EP0712401A1 (en) | 1996-05-22 |
| MA23563A1 (fr) | 1995-12-31 |
| NO960268D0 (no) | 1996-01-23 |
| BR9506235A (pt) | 1997-08-12 |
| WO1995032959A1 (en) | 1995-12-07 |
| IS4321A (is) | 1996-01-17 |
| ZA954125B (en) | 1995-11-27 |
| AU2633095A (en) | 1995-12-21 |
| PL312692A1 (en) | 1996-05-13 |
| JPH09504557A (ja) | 1997-05-06 |
| CA2166988A1 (en) | 1995-12-07 |
| FI960367L (fi) | 1996-01-26 |
| HU9600005D0 (en) | 1996-03-28 |
| TNSN95062A1 (fr) | 1996-02-06 |
| FI960367A0 (fi) | 1996-01-26 |
| EE9600011A (et) | 1996-04-15 |
| CN1128997A (zh) | 1996-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY121192A (en) | New compounds. | |
| NO960268L (no) | Nye dialkoksypyridinylbenzimidazolderivater | |
| NO160204C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkalisalter av 5-metoksy-2(((4-metoksy-3,5-dimetyl-2-pyridinyl)-metyl)-sulfinyl)-1h-benzimidazol. | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| ES2108717T3 (es) | Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| IL57324A (en) | 3-substituted-6-alkanoylamino-1,3,5-triazine-2,4-diones,process for their preparation and pharmaceutical compositions containing them | |
| NO178338C (no) | Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse samt mellomprodukt | |
| IL92799A0 (en) | Benzimidazole derivatives with gastric acid inhibition and process for its preparation | |
| AU7817087A (en) | 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use | |
| MX9806229A (es) | Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas. | |
| ES8100263A1 (es) | Procedimiento para preparar un derivado de acido 1-bencil-1,2,5,6-tetrahidropiridina-3-carboxilico | |
| NO960267L (no) | Nye substituerte benzimidazoler | |
| AU545254B2 (en) | Benzo (4,5) pyrano (2,3c) pyrroles, processes for their preparation and pharmaceutical preparations containing same | |
| JO1871B1 (en) | Innovative substituted benzimidazole compounds | |
| AU1390692A (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
| JO1870B1 (en) | CO2 derivatives - pyridinyl benzimidazole innovative | |
| EP0192393A3 (en) | Alkylaminofuranone derivatives | |
| FI893570A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten 1H-imidatso/1,2-b/-pyratsolin johdannaisten valmistamiseksi | |
| AU617849B2 (en) | New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them | |
| DE69000806D1 (de) | Indol-derivate. | |
| CS725786A2 (en) | Zpusob vyroby novych 2 (2 thienyl)imidazo (4,5 c)pyridinovych derivatu | |
| DK210387A (da) | Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse | |
| JO1660B1 (en) | Benzimidazole compounds are a therapeutically effective substitute for chlorine and processes for preparing and using them |